High-purity preparation of HSV-2 vaccine candidate ACAM529 is immunogenic and efficacious in vivo.
Genital herpes is a sexually transmitted infection (STI) caused by herpes simplex virus 2 (HSV-2) and to a lesser extent herpes simplex virus 1 (HSV-1). Infection by HSV-2 is life-long and is associated with significant cost to healthcare systems and social stigma despite the highly prevalent nature...
Guardado en:
Autores principales: | Sophia T Mundle, Hector Hernandez, John Hamberger, John Catalan, Changhong Zhou, Svetlana Stegalkina, Andrea Tiffany, Harry Kleanthous, Simon Delagrave, Stephen F Anderson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d67d7fbcea1545a78cf5d2f5c0f3bbb7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Acta Nº529
por: Banco Central de Chile
Publicado: (2019) -
Immunogenicity of a DNA vaccine candidate for COVID-19
por: Trevor R. F. Smith, et al.
Publicado: (2020) -
A multi-targeted drug candidate with dual anti-HIV and anti-HSV activity.
por: Jan Balzarini, et al.
Publicado: (2013) -
Epistles of the Brethren of Purity
por: Sajjad Rizvi
Publicado: (2016) -
Epistles of the Brethren of Purity. On the Natural Sciences
por: Sajjad Rizvi
Publicado: (2014)